Kerr, Phoebe
Cossar, Reece D.
Livingston, Michael
Jacka, David
Dietze, Paul
O’Keefe, Daniel
Article History
Received: 14 October 2022
Accepted: 8 December 2022
First Online: 21 December 2022
Declarations
:
: Not applicable.
: Not applicable.
: PD is supported by NHMRC Research Fellowships (#1136908). PD has received investigator initiated research funding from Gilead Sciences and an untied educational grant from Indivior unrelated to this study. PD has served as an unpaid member of an advisory board for an intranasal naloxone product. All other authors have nothing to declare.